Finance

Business Forum   |   31 January, 2025 at 1:13 PM

Dealmaking volume stable but value is down

65% of all big pharma revenues now come from dealmaking, confirming a need for robust inorganic growth and value creation strategies.

RECOMMENDED FROM THE HOME PAGE
Energy

OMV Petrom locks in €800 million biofuels supply deal

OMV Petrom concluded a sales contract with OMV Downstream GmbH, a fully owned subsidiary of OMV AG, for part of the Sustainable Aviation Fuel (SAF) and Hydrotreated Vegetable Oil (HVO) to be produced at the Petrobrazi refinery.